Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.01 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/24/15 All times are local (Market data is delayed by at least 15 minutes).

bio-bridge science inc (BGES) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/21/15 - $0.01
52 Week Low
06/4/15 - $0.0005
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO-BRIDGE SCIENCE INC (BGES)

Related News

No related news articles were found.

bio-bridge science inc (BGES) Related Businessweek News

No Related Businessweek News Found

bio-bridge science inc (BGES) Details

Bio-Bridge Science Inc., a biotechnology company, focuses on the commercial development of vaccines for the prevention and treatment of human immunodeficiency virus (HIV) diseases. Its products under development include a HIV vaccine to prevent acquired immunodeficiency syndrome; a colon cancer therapeutic vaccine; HIV-PV vaccine for the prevention of cervical cancer; and mucosal adjuvant products. The company holds license for the HIV vaccine and colon cancer vaccine technology with respect to development and sale in the territories of the People’s Republic of China, Japan, and the United States. It also offers vaccine production-related materials. The company was founded in 2002 and is based in Oak Brook, Illinois.

23 Employees
Last Reported Date: 04/15/11
Founded in 2002

bio-bridge science inc (BGES) Top Compensated Officers

Co-Founder, Chairman and Secretary
Total Annual Compensation: --
Co-Founder and Director
Total Annual Compensation: --
Co-Founder and Director
Total Annual Compensation: --
Principal Financial Officer and Controller
Total Annual Compensation: --
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BGES:US $0.01 USD 0.00

BGES Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BGES.
View Industry Companies

Industry Analysis


Industry Average

Valuation BGES Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.0x
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-BRIDGE SCIENCE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at